Hematology TimesHormone therapy may decrease risk of NHLApril 9, 2014Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Oncology PracticeACA coverage may lead to more malpractice claimsApril 9, 2014Practice ManagementBusiness of Medicine
Oncology PracticeIOM identifies 17 social factors to collect in EHRsApril 8, 2014Practice ManagementBusiness of Medicine
Oncology PracticeConventional chemo bests tyrosine kinase inhibitors in wild-type lung cancersApril 8, 2014Lung Cancer
Oncology PracticeCopy and paste at your own risk: The dangers of electronic ‘plagiarism’April 8, 2014Practice ManagementBusiness of Medicine
Oncology PracticeExchanges reaching previously uninsured, say health system execsApril 8, 2014Practice ManagementBusiness of Medicine
Hematology TimesGood or bad, immune responses to cancer are similarApril 8, 2014Lymphoma & Plasma Cell DisordersRelated Issues
Hematology TimesEnrollment stalled for CAR T-cell studyApril 8, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
Oncology PracticePatients with PD-L1–positive tumors had better response to immune checkpoint inhibitorApril 7, 2014Lung CancerMelanoma
Hematology TimesHow autophagy helps cancer cells evade deathApril 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Oncology PracticeDepression at least five times more common than PTSD after critical illnessApril 6, 2014Patient & Survivor Care
